$18.75
arrow_drop_up4.16%Key Stats | |
---|---|
Open | $18.35 |
Prev. Close | $18.00 |
EPS | -3.40 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 17.85 | 18.44 |
52 Week Range | 11.21 | 25.34 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -3.40 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
Syndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDA
Syndax (SNDX) is on the Move, Here's Why the Trend Could be Sustainable
Incyte's (INCY) Q4 Earnings & Revenues Fall Shy of Estimates
Analyst Ratings for Syndax Pharmaceuticals
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2023